GlassScriptPhysician profile
Brandy Standifer
NPI 1932845153
$2,612.03
in general payments reported to CMS, 2019-2025
23 companies · $707 in 2025
The $707 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $311 · 2023: $892 · 2024: $701 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,202 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,201.88 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $819.30 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $405.74 | 2022-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $267.15 | 2022-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $183.02 | 2022-2023 | Verquvo |
| Pfizer INC. | $165.52 | 2022-2025 | |
| Actelion Pharmaceuticals US, INC. | $123.21 | 2023 | Uptravi, Opsumit |
| Abbott Laboratories | $82.62 | 2025 | Cardiomems |
| United Therapeutics Corporation | $78.78 | 2024-2025 | Tyvaso, Tyvaso |
| Astrazeneca Pharmaceuticals LP | $74.07 | 2023-2025 | Brilinta, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $58.42 | 2022-2025 | Eliquis |
| Novo Nordisk INC | $54.12 | 2025 | Wegovy |
| Boston Scientific Corporation | $50.05 | 2022-2025 | Bodyguardian, Watchman Flx |
| Atricure, INC. | $45.98 | 2024-2025 | Atriclip Laa Exclusion System |
| Abiomed | $38.38 | 2024 | Impella |
| Amgen INC. | $35.53 | 2023 | Repatha |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $21.91 | 2025 | Inspire |
| Davol INC. | $19.90 | 2023 | Arista Ah Flexitip |
| Alnylam Pharmaceuticals INC. | $17.86 | 2025 | Onpattro |
| Daiichi Sankyo INC. | $17.70 | 2023 | Injectafer |
| Surmodics, INC. | $15.23 | 2025 | Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy, Pounce Thrombectomy System |
| Bolton Medical INC | $13.82 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| La Jolla Pharmaceutical Company | $12.97 | 2023 | Giapreza |
| Lemaitre Vascular, INC. | $10.75 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Standifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.